Cargando…

Type 3 Gaucher disease, diagnostic in adulthood

Detalles Bibliográficos
Autores principales:	Detollenaere, Charles, Benghergbia, Monia, Brassier, Anaïs, de Villemeur, Thierry Billette, Amsallem, Daniel, Berger, Marc, Stirnemann, Jérôme, Belmatoug, Nadia, Rose, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508612/ https://www.ncbi.nlm.nih.gov/pubmed/28736718 http://dx.doi.org/10.1016/j.ymgmr.2017.07.002

Ejemplares similares

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
por: Stirnemann, Jérôme, et al.
Publicado: (2017)

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
por: Nguyen, Yann, et al.
Publicado: (2020)

Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease
por: Lefebvre, Thibaud, et al.
Publicado: (2018)

A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
por: Serratrice, Christine, et al.
Publicado: (2020)

The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
por: Stirnemann, Jérôme, et al.
Publicado: (2012)

Effects of sphingolipids overload on red blood cell properties in Gaucher disease
por: Dupuis, Lucie, et al.
Publicado: (2020)

Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2018)

Bone events and evolution of biologic markers in Gaucher disease before and during treatment
por: Stirnemann, Jérôme, et al.
Publicado: (2010)

Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1
por: Stirnemann, Jérôme, et al.
Publicado: (2015)

Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
por: Vigan, Marie, et al.
Publicado: (2014)

Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells
por: Dupuis, Lucie, et al.
Publicado: (2022)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Gaucher Disease in Bone: From Pathophysiology to Practice
por: Hughes, Derralynn, et al.
Publicado: (2019)

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
por: Serratrice, Christine, et al.
Publicado: (2016)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Early detection of median nerve compression by Electroneurography can improve outcome in children with Mucopolysaccharidoses
por: Maincent, Kim, et al.
Publicado: (2018)

Exodontia in patient with Gaucher's disease
por: Lisboa, Guacyra Machado, et al.
Publicado: (2011)

Pulmonary involvement in Gaucher disease
por: de Farias, Lucas de Pádua Gomes, et al.
Publicado: (2017)

Splenic Artery Aneurysms, a Rare Complication of Type 1 Gaucher Disease: Report of Five Cases
por: Serratrice, Christine, et al.
Publicado: (2019)

Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities—the TENALYS study, a patient perspective survey
por: Genevaz, Delphine, et al.
Publicado: (2022)

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data
por: Raskovalova, Tatiana, et al.
Publicado: (2017)

A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients
por: Lecourt, Séverine, et al.
Publicado: (2013)

Hepatocellular carcinoma in Gaucher disease: an international case series
por: Regenboog, Martine, et al.
Publicado: (2018)

Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis
por: Billette de Villemeur, Agathe, et al.
Publicado: (2020)

Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative
por: Mehta, Atul, et al.
Publicado: (2019)

Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials
por: Lukina, Elena, et al.
Publicado: (2020)

Quality of life in patients with locked-in syndrome: Evolution over a 6-year period
por: Rousseau, Marie-Christine, et al.
Publicado: (2015)

Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures
por: Rim, John Hoon, et al.
Publicado: (2016)

Breastfeeding in patients with Gaucher disease: Is taliglucerase alfa safe?
por: Paskulin, Livia, et al.
Publicado: (2019)

Gaucher disease in a 53-year-old Iranian man
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Hemophagocytic Lymphohistiocytosis Syndrome Associated with Gaucher Disease Type 2
por: Gholamreza, Bahoush, et al.
Publicado: (2014)

Assessment of quality of life in Gaucher disease: A methodological approach
por: Zizemer, Vitória S., et al.
Publicado: (2020)

Adequacy of care management of patients with polyhandicap in the French health system: A study of 782 patients
por: Rousseau, Marie-Christine, et al.
Publicado: (2018)

A Letter from Brian Berman, President, National Gaucher Foundation
Publicado: (2018)

The French EVAL-PLH cohort of persons with polyhandicap
por: Hamouda, Ilyes, et al.
Publicado: (2022)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

Gaucher disease in Iraqi children (Clinical, diagnostic & therapeutic aspects)
por: Thejeal, Rabab Farhan, et al.
Publicado: (2016)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q60k63ovc1kni04j03lc4mpcto